Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

PHR

Phreesia Inc

Oct 07 • 01:19PM ET

21.66

Dollar change -0.53
Percentage change -2.39	%

Healthcare • Health Information Services • USA • NYSE

Held by: VTI IWM VXF VB IWO VBK SCHA VTWO VHT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.80	Insider Own	6.62%	Shs Outstand	56.35M	Perf Week	-4.96%
Market Cap	1.25B	Forward P/E	-	EPS next Y	-0.61	Insider Trans	-3.02%	Shs Float	53.95M	Perf Month	-8.03%
Income	-100.32M	PEG	-	EPS next Q	-0.27	Inst Own	94.83%	Short Float	5.02%	Perf Quarter	7.01%
Sales	389.96M	P/S	3.21	EPS this Y	52.76%	Inst Trans	6.79%	Short Ratio	6.98	Perf Half Y	-5.38%
Book/sh	4.36	P/B	4.97	EPS next Y	48.77%	ROA	-28.55%	Short Interest	2.71M	Perf Year	20.73%
Cash/sh	1.42	P/C	15.30	EPS next 5Y	-	ROE	-40.26%	52W Range	12.05 - 29.16	Perf YTD	-6.44%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.39%	ROI	-38.63%	52W High	-25.71%	Beta	0.92
Dividend TTM	-	Quick Ratio	1.77	Sales past 5Y	29.21%	Gross Margin	58.96%	52W Low	79.74%	ATR (14)	1.02
Dividend Ex-Date	-	Current Ratio	1.77	EPS Y/Y TTM	37.24%	Oper. Margin	-24.58%	RSI (14)	36.57	Volatility	3.25% 4.39%
Employees	1438	Debt/Eq	0.07	Sales Y/Y TTM	22.10%	Profit Margin	-25.73%	Recom	1.29	Target Price	29.31
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	54.18%	Payout	-	Rel Volume	0.39	Prev Close	22.19
Sales Surprise	0.51%	EPS Surprise	12.45%	Sales Q/Q	18.97%	Earnings	Sep 04 AMC	Avg Volume	387.98K	Price	21.66
SMA20	-6.88%	SMA50	-9.11%	SMA200	-6.91%	Trades		Volume	91,302	Change	-2.39%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37
Jan-04-23	Reiterated	Needham	Buy	$35 → $40
Dec-13-22	Upgrade	Citigroup	Neutral → Buy	$40
Dec-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$31 → $34
Oct-13-22	Initiated	DA Davidson	Neutral	$25
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$40
Apr-14-22	Initiated	Guggenheim	Buy	$45
Jan-06-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$57 → $41
Dec-02-21	Initiated	Jefferies	Buy	$70
Sep-02-21	Reiterated	Needham	Buy	$70 → $81
Aug-27-21	Initiated	Canaccord Genuity	Buy	$81
Jul-13-21	Initiated	JMP Securities	Mkt Outperform	$80
Jun-08-21	Initiated	Berenberg	Buy	$70
Apr-29-21	Resumed	JP Morgan	Overweight	$64
Apr-01-21	Initiated	Robert W. Baird	Outperform	$60
Nov-11-20	Initiated	Stephens	Overweight	$50
Oct-27-20	Initiated	Needham	Buy	$44

Show Previous Ratings

Oct-03-24 06:48AM	Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns (Business Wire)
Oct-01-24 06:48AM	Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model (Business Wire)
Sep-19-24 06:48AM	New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption (Business Wire)
Sep-17-24 04:28PM	CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence (Business Wire)
Sep-05-24 12:39PM	Q2 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
06:00PM	Loading…
Sep-04-24 06:00PM	Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2025 Results (Business Wire)
Sep-03-24 09:03AM	Earnings To Watch: Phreesia Inc (PHR) Reports Q2 2025 Result (GuruFocus.com) -7.43%
Aug-29-24 09:15AM	Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
06:48AM	Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination (Business Wire)
Aug-08-24 06:48AM	Bob Glazer Joins Phreesia as Strategic Advisor (Business Wire)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results (Business Wire)
06:48AM	Loading…
Jul-30-24 06:48AM	Phreesia Now Available on Oracle Healthcare Marketplace (Business Wire)
Jul-19-24 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet (Zacks)
Jul-12-24 12:00PM	Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jun-10-24 10:26AM	New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease (Business Wire)
Jun-04-24 09:35AM	Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks (Zacks)
May-31-24 11:59AM	Q1 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM	PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025 (InvestorPlace)
05:30PM	Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2025 Results (Business Wire)
May-28-24 06:48AM	Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner (Business Wire)
May-24-24 09:15AM	Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-23-24 04:30PM	Phreesias Amy Patel Named One of PM360s 2024 ELITE 100 (Business Wire)
May-21-24 04:30PM	Phreesia Named as One of Modern Healthcares Best Places to Work in Healthcare for the Eighth Time (Business Wire)
06:46AM	Loading…
May-01-24 06:46AM	Phreesias Alicia Cowley and Natasha Vega Named to MM+Ms Women to Watch for 2024 (Business Wire)
Apr-29-24 06:48AM	Phreesia Sets Release Date for Fiscal First Quarter 2025 Results (Business Wire)
Mar-25-24 07:01PM	Insider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Mar-19-24 06:48AM	Phreesia Announces Jack Callahan as New Chief Technology Officer (Business Wire)
Mar-17-24 10:22AM	Phreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-15-24 06:56AM	Q4 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024 (InvestorPlace)
06:00PM	Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2024 Results (Business Wire)
Mar-07-24 10:00AM	Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-27-24 04:05PM	Phreesias Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium (Business Wire)
Feb-20-24 06:48AM	New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates (Business Wire) -6.32%
Feb-19-24 11:53AM	Phreesia (PHR) Rose on 2024 Guidance (Insider Monkey)
Feb-05-24 04:05PM	Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results (Business Wire)
06:54AM	Bull Of The Day: Phreesia (PHR) (Zacks)
Jan-23-24 06:40AM	Phreesia Joins Call to Action to Improve Adult Vaccination Rates (Business Wire)
Jan-18-24 07:59PM	Phreesia Inc CFO Balaji Gandhi Sells 10,124 Shares (GuruFocus.com)
Jan-16-24 04:05PM	Phreesias Audrey Gato Named as a Top Woman Leader in SaaS (Business Wire)
Jan-11-24 06:44AM	Phreesias Post-Script Engagement named one of PM360s 2023 Most Innovative Technologies (Business Wire)
Dec-27-23 09:55AM	Does Phreesia (PHR) Have the Potential to Rally 30.09% as Wall Street Analysts Expect? (Zacks)
08:06AM	What Caused a -40% Drop in Phreesia (PHR) Shares? (Insider Monkey)
Dec-11-23 09:55AM	Wall Street Analysts Predict a 77.77% Upside in Phreesia (PHR): Here's What You Should Know (Zacks)
Dec-08-23 08:21AM	Phreesia, Inc. (NYSE:PHR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Dec-06-23 10:37AM	Q3 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +21.22%
Dec-05-23 06:00PM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q3 Earnings (Zacks)
05:40PM	Phreesia Inc (PHR) Reports Revenue Growth and Narrowed Net Loss in Q3 Fiscal 2024 (GuruFocus.com)
05:15PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:17PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Third Quarter Fiscal 2024 Results (Business Wire)
Dec-01-23 06:00AM	CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024 (Business Wire)
Nov-16-23 03:12AM	Here's Why Phreesia (PHR) Declined in Q3 (Insider Monkey)
Nov-08-23 06:00AM	Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance (Business Wire)
Nov-01-23 09:12AM	Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains? (Zacks)
06:03AM	Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results (Business Wire)
Sep-15-23 10:01PM	Insider Sell: Evan Roberts Sells 3,907 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Sep-14-23 09:39PM	Principal Accounting Officer Janet Gunzburg Sells 934 Shares of Phreesia Inc (GuruFocus.com)
Sep-11-23 12:11PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com)
Sep-07-23 12:08PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com) -22.11%
11:45AM	Is Phreesia (PHR) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
09:30AM	Compared to Estimates, Phreesia (PHR) Q2 Earnings: A Look at Key Metrics (Zacks)
09:00AM	Phreesia, Inc. (NYSE:PHR) Q2 2024 Earnings Call Transcript (Insider Monkey)
07:37AM	Q2 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-06-23 05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Phreesia: Fiscal Q2 Earnings Snapshot (AP Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2024 Results (Business Wire)
Sep-04-23 12:00PM	All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy (Zacks)
09:55AM	How Much Upside is Left in Phreesia (PHR)? Wall Street Analysts Think 27.26% (Zacks)
08:39AM	Nextgen Healthcare (NXGN) Surges 6.2%: Is This an Indication of Further Gains? (Zacks)
Aug-31-23 08:40AM	Should You Buy and Phreesia (PHR) Ahead of Earnings? (Zacks)
Aug-16-23 12:58PM	Phreesia Named to The Software Reports "Top 100 Software Companies" for the Second Consecutive Year (Business Wire)
Aug-15-23 05:11PM	Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms (Business Wire)
Aug-14-23 04:03PM	Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience (Business Wire)
Aug-07-23 06:50PM	Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-01-23 06:03AM	Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results (Business Wire)
Jul-20-23 08:40PM	Analysts Say These 3 Stocks Are Their Top Picks for the Rest of 2023 (TipRanks)
Jul-14-23 04:48PM	Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers (Business Wire)
Jul-13-23 04:03PM	Phreesia Names Lisa Egbuonu-Davis to its Board of Directors (Business Wire)
Jul-11-23 12:00PM	Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jun-13-23 06:43AM	We're Not Very Worried About Phreesia's (NYSE:PHR) Cash Burn Rate (Simply Wall St.)
May-31-23 06:30PM	Phreesia (PHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (AP Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2024 Results (Business Wire)
May-17-23 04:03PM	Phreesia Recognized as One of Modern Healthcares "Best Places to Work in Healthcare" for a Seventh Year (Business Wire)
May-16-23 04:05PM	Phreesias Hilary Hatch Named a "Disrupter" in PM360s ELITE 100 (Business Wire)
May-15-23 05:45PM	Tivic Health Systems, Inc. (TIVC) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +7.26%
May-11-23 05:35PM	Homology Medicines (FIXX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-09-23 05:35PM	Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.56% +7.68%

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Linetsky David	SVP, Life Sciences	Sep 19 '24	Sale	24.04	24	577	8,971	Sep 20 04:39 PM
Linetsky David	SVP, Life Sciences	Sep 18 '24	Sale	24.09	61	1,469	8,995	Sep 19 05:49 PM
Linetsky David	SVP, Life Sciences	Sep 17 '24	Sale	24.77	36	892	9,056	Sep 19 05:49 PM
Linetsky David	Member of immediate family of	Sep 19 '24	Proposed Sale	24.04	24	577		Sep 19 04:13 PM
Linetsky David	Member of immediate family of	Sep 18 '24	Proposed Sale	24.09	61	1,469		Sep 18 03:51 PM
Linetsky David	Member of immediate family of	Sep 17 '24	Proposed Sale	24.77	36	892		Sep 17 03:38 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Sale	23.03	1,400	32,239	18,139	Sep 13 04:06 PM
Gandhi Balaji	Chief Financial Officer	Sep 10 '24	Sale	23.25	3,502	81,422	98,578	Sep 12 06:03 PM
Hui Yvonne	Principal Accounting Officer	Sep 10 '24	Sale	23.25	744	17,298	30,019	Sep 12 06:02 PM
Indig Chaim	Chief Executive Officer	Sep 10 '24	Sale	23.25	5,295	123,110	1,223,736	Sep 12 06:00 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	1,716	39,897	203,318	Sep 12 05:58 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	95	2,209	9,092	Sep 12 05:58 PM
Roberts Evan	Chief Operating Officer	Sep 10 '24	Sale	23.25	3,148	73,192	755,719	Sep 12 05:55 PM
VanDuyn Amy Beth	SVP, Human Resources	Sep 10 '24	Sale	23.25	737	17,135	119,541	Sep 12 05:53 PM
Hoffman Allison C	General Counsel & Secretary	Sep 10 '24	Sale	23.25	2,622	60,962	123,075	Sep 12 05:51 PM
Hoffman Allison C	General Counsel & Secretary	Sep 11 '24	Sale	23.36	2,072	48,402	121,003	Sep 12 05:51 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Proposed Sale	23.03	1,400	32,239		Sep 12 02:04 PM
Hoffman Allison C	Officer	Sep 11 '24	Proposed Sale	23.36	2,072	48,402		Sep 11 09:54 AM
Indig Chaim	Officer	Sep 10 '24	Proposed Sale	23.25	5,295	123,110		Sep 10 05:00 PM
Roberts Evan	Officer	Sep 10 '24	Proposed Sale	23.25	3,148	73,192		Sep 10 04:52 PM
VanDuyn Amy Beth	Officer	Sep 10 '24	Proposed Sale	23.25	737	17,135		Sep 10 04:48 PM
Linetsky David	Member of immediate family of	Sep 10 '24	Proposed Sale	23.25	95	2,209		Sep 10 04:48 PM
Hoffman Allison C	Officer	Sep 10 '24	Proposed Sale	23.25	2,622	60,962		Sep 10 04:38 PM
Gandhi Balaji	Officer	Sep 10 '24	Proposed Sale	23.25	3,502	81,422		Sep 10 04:32 PM
Linetsky David	Officer	Sep 10 '24	Proposed Sale	23.25	1,716	39,897		Sep 10 04:28 PM
Hui Yvonne	Officer	Sep 10 '24	Proposed Sale	23.25	744	17,298		Sep 10 04:18 PM
Hoffman Allison C	General Counsel & Secretary	Aug 26 '24	Sale	26.03	14,110	367,241	121,003	Aug 28 04:57 PM
Hoffman Allison C	Officer	Aug 26 '24	Proposed Sale	26.03	14,110	367,244		Aug 26 03:17 PM
Indig Chaim	Chief Executive Officer	Jul 29 '24	Option Exercise	2.03	7	14	1,219,368	Jul 30 05:05 PM
Indig Chaim	Chief Executive Officer	Jul 29 '24	Sale	24.75	7	173	1,219,361	Jul 30 05:05 PM
Gunzburg Janet	Officer	Jul 29 '24	Proposed Sale	24.64	202	4,977		Jul 29 03:36 PM
Indig Chaim	Officer	Jul 29 '24	Proposed Sale	24.75	7	173		Jul 29 11:12 AM
Smith Mark Douglas	Director	Jul 18 '24	Option Exercise	4.71	7,000	32,970	37,653	Jul 22 04:56 PM
Smith Mark Douglas	Director	Jul 18 '24	Sale	25.00	7,000	175,000	30,653	Jul 22 04:56 PM
Linetsky David	SVP, Life Sciences	Jul 16 '24	Sale	23.74	1,820	43,199	202,218	Jul 17 05:31 PM
Indig Chaim	Chief Executive Officer	Jul 16 '24	Sale	23.74	2,644	62,757	1,219,361	Jul 17 05:30 PM
Hui Yvonne	Principal Accounting Officer	Jul 16 '24	Sale	23.74	283	6,717	28,714	Jul 17 05:29 PM
Hoffman Allison C	General Counsel & Secretary	Jul 16 '24	Sale	23.74	800	18,988	135,113	Jul 17 05:28 PM
Gandhi Balaji	Chief Financial Officer	Jul 16 '24	Sale	23.74	783	18,585	96,447	Jul 17 05:27 PM
VanDuyn Amy Beth	SVP, Human Resources	Jul 16 '24	Sale	23.74	374	8,877	118,636	Jul 17 05:26 PM
Roberts Evan	Chief Operating Officer	Jul 16 '24	Sale	23.74	1,669	39,615	753,234	Jul 17 05:24 PM
Gunzburg Janet	Principal Accounting Officer	Jun 21 '24	Sale	20.24	114	2,307	34,820	Jun 24 04:30 PM
Linetsky David	SVP, Life Sciences	Jun 21 '24	Sale	20.24	27	546	6,953	Jun 24 04:29 PM
Linetsky David	SVP, Life Sciences	Jun 20 '24	Sale	19.73	66	1,302	6,980	Jun 21 04:35 PM
Linetsky David	SVP, Life Sciences	Jun 18 '24	Sale	19.20	41	787	7,046	Jun 21 04:35 PM
Gunzburg Janet	Principal Accounting Officer	May 01 '24	Sale	21.00	286	6,006	34,934	May 02 04:22 PM
Gunzburg Janet	Principal Accounting Officer	Apr 18 '24	Sale	22.85	912	20,836	35,220	Apr 19 04:24 PM
Linetsky David	SVP, Life Sciences	Apr 18 '24	Sale	22.85	269	6,146	7,087	Apr 19 04:24 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 15 '24	Sale	22.86	685	15,657	119,010	Apr 17 04:13 PM
Linetsky David	SVP, Life Sciences	Apr 15 '24	Sale	22.86	2,212	50,561	204,038	Apr 17 04:13 PM
Roberts Evan	Chief Operating Officer	Apr 15 '24	Sale	22.86	2,029	46,378	754,903	Apr 17 04:13 PM
Hoffman Allison C	General Counsel & Secretary	Apr 15 '24	Sale	22.86	1,238	28,297	135,621	Apr 17 04:10 PM
Gandhi Balaji	Chief Financial Officer	Apr 15 '24	Sale	22.86	948	21,669	97,230	Apr 17 04:08 PM
Indig Chaim	Chief Executive Officer	Apr 15 '24	Sale	22.86	3,392	77,532	1,222,005	Apr 17 04:07 PM
Gunzburg Janet	Principal Accounting Officer	Apr 10 '24	Sale	23.10	2,768	63,928	36,132	Apr 12 06:40 PM
Hoffman Allison C	General Counsel & Secretary	Apr 08 '24	Sale	22.62	5,549	125,519	141,485	Apr 10 05:20 PM
Hoffman Allison C	General Counsel & Secretary	Apr 09 '24	Sale	23.42	4,626	108,360	136,859	Apr 10 05:20 PM
Gandhi Balaji	Chief Financial Officer	Apr 08 '24	Sale	22.62	7,778	175,939	98,178	Apr 10 05:19 PM
Indig Chaim	Chief Executive Officer	Apr 08 '24	Sale	22.62	12,043	272,414	1,225,397	Apr 10 05:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 09 '24	Sale	23.43	3,768	88,277	119,695	Apr 10 05:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 08 '24	Sale	22.62	3,354	75,868	123,463	Apr 10 05:19 PM
Roberts Evan	Chief Operating Officer	Apr 09 '24	Option Exercise	2.03	23,330	47,360	756,932	Apr 10 05:18 PM
Roberts Evan	Chief Operating Officer	Apr 08 '24	Sale	22.62	7,178	162,367	733,602	Apr 10 05:18 PM
Linetsky David	SVP, Life Sciences	Apr 08 '24	Sale	22.62	3,914	88,535	206,250	Apr 10 05:18 PM
Linetsky David	SVP, Life Sciences	Apr 08 '24	Sale	22.62	247	5,587	7,356	Apr 10 05:18 PM
Gunzburg Janet	Principal Accounting Officer	Mar 19 '24	Sale	23.27	2,817	65,561	40,609	Apr 10 05:18 PM
Gunzburg Janet	Principal Accounting Officer	Apr 08 '24	Sale	22.62	1,709	38,658	38,900	Apr 10 05:18 PM
Gandhi Balaji	Chief Financial Officer	Mar 25 '24	Sale	23.21	3,504	81,332	94,030	Mar 27 04:06 PM
Roberts Evan	Chief Operating Officer	Mar 21 '24	Sale	23.52	25,962	610,684	728,570	Mar 25 04:16 PM
Gunzburg Janet	Principal Accounting Officer	Mar 20 '24	Sale	23.66	137	3,241	38,949	Mar 21 04:11 PM
Linetsky David	SVP, Life Sciences	Mar 20 '24	Sale	23.66	30	710	7,095	Mar 21 04:11 PM
Linetsky David	SVP, Life Sciences	Mar 19 '24	Sale	23.27	402	9,356	7,125	Mar 20 04:21 PM
Linetsky David	SVP, Life Sciences	Mar 18 '24	Sale	22.22	46	1,022	7,527	Mar 20 04:21 PM
Gunzburg Janet	Principal Accounting Officer	Feb 09 '24	Sale	28.00	480	13,440	39,086	Feb 13 04:58 PM
Gunzburg Janet	Principal Accounting Officer	Feb 02 '24	Sale	27.00	480	12,960	39,566	Feb 06 04:22 PM
Gunzburg Janet	Principal Accounting Officer	Feb 01 '24	Sale	25.99	328	8,525	40,046	Feb 02 06:06 PM
Gunzburg Janet	Principal Accounting Officer	Jan 12 '24	Sale	24.11	205	4,943	40,374	Feb 02 06:06 PM
Gandhi Balaji	Chief Financial Officer	Jan 17 '24	Sale	24.12	9,192	221,726	97,534	Jan 18 04:53 PM
Gandhi Balaji	Chief Financial Officer	Jan 16 '24	Sale	24.55	932	22,876	106,726	Jan 18 04:53 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 17 '24	Sale	24.12	10,213	246,354	119,695	Jan 18 04:53 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 16 '24	Sale	24.55	738	18,115	129,908	Jan 18 04:53 PM
Davidoff Michael J.	SVP, Payer Business	Jan 17 '24	Sale	24.12	17,677	426,398	73,391	Jan 18 04:53 PM
Davidoff Michael J.	SVP, Payer Business	Jan 16 '24	Sale	24.55	1,310	32,155	91,068	Jan 18 04:53 PM
Linetsky David	SVP, Life Sciences	Jan 17 '24	Sale	24.12	30,659	739,544	204,059	Jan 18 04:52 PM
Linetsky David	SVP, Life Sciences	Jan 16 '24	Sale	24.55	2,318	56,896	234,718	Jan 18 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 17 '24	Sale	24.12	7,605	183,445	136,859	Jan 18 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 16 '24	Sale	24.55	1,316	32,302	144,464	Jan 18 04:52 PM
Roberts Evan	Chief Operating Officer	Jan 17 '24	Sale	24.12	41,081	990,939	754,532	Jan 18 04:52 PM
Roberts Evan	Chief Operating Officer	Jan 16 '24	Sale	24.55	2,247	55,154	795,613	Jan 18 04:52 PM
Indig Chaim	Chief Executive Officer	Jan 17 '24	Sale	24.12	63,931	1,542,118	1,216,479	Jan 18 04:51 PM
Indig Chaim	Chief Executive Officer	Jan 16 '24	Sale	24.55	3,586	88,020	1,280,410	Jan 18 04:51 PM
Gunzburg Janet	Principal Accounting Officer	Dec 19 '23	Sale	23.72	118	2,799	40,579	Dec 20 04:14 PM
Linetsky David	SVP, Life Sciences	Dec 18 '23	Sale	23.15	234	5,418	7,598	Dec 20 04:13 PM
Linetsky David	SVP, Life Sciences	Dec 19 '23	Sale	23.72	25	593	7,573	Dec 20 04:13 PM
Gunzburg Janet	Principal Accounting Officer	Nov 01 '23	Sale	13.38	298	3,988	40,697	Nov 02 04:39 PM
Roberts Evan	Chief Operating Officer	Oct 31 '23	Option Exercise	2.03	30,000	60,900	775,860	Nov 02 04:36 PM
Davidoff Michael J.	SVP, Payer Business	Oct 16 '23	Sale	16.61	1,198	19,898	92,378	Oct 17 06:22 PM
Gandhi Balaji	Chief Financial Officer	Oct 16 '23	Sale	16.61	861	14,300	85,658	Oct 17 06:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Oct 16 '23	Sale	16.61	665	11,045	118,146	Oct 17 06:17 PM
Hoffman Allison C	General Counsel & Secretary	Oct 16 '23	Sale	16.61	1,297	21,542	115,025	Oct 17 06:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PHR

Phreesia Inc

Upgrade your FINVIZ experience